Amgen | A Worldwide Pioneer in Biotechnology

$name
$name

Science & Innovation 10.03.2023

How AI and Life Sciences Research Are Revolutionizing Protein Drug Development

Amgen researchers use generative biology to accelerate and improve protein drug development by combining artificial intelligence and machine learning with automated, high-throughput lab-based science.
Read Story
Arrow
❮1 / 6❯
$name
$name

Responsibilty 09.29.2023

Paving Her Own Path
Read Story
Arrow
❮2 / 6❯
$name
$name

Leadership 09.28.2023

Arleen Paulino, SVP of Manufacturing, Inducted Into Women in Manufacturing Hall of Fame
Read Story
Arrow
❮3 / 6❯
$name
$name

Science & Innovation 09.21.2023

Big Data and AI Give Patients with Genetic Cholesterol Disorder a Head Start on Better Health
Read Story
Arrow
❮4 / 6❯
$name
$name

Science & Innovation 09.20.2023

Amgen Partners of Choice Inaugural Summit Convenes Clinical Leaders to Improve Patient Care
Read Story
Arrow
❮5 / 6❯
$name
$name

Responsibility 09.18.2023

Amgen Origins: Bond Between Amgen Foundation and Nurses Goes Back Decades
Read Story
Arrow
❮6 / 6❯
$link.Title
RESPONSIBILITY 09.11.2023

Amgen Origins: Post 9/11, Dora’s Legacy Endures Through Cancer Care
$link.Title
PATIENTS 09.07.2023

One Simple Way People Who’ve Had a Heart Attack or Stroke Can Reduce Cardiovascular Risk
PRESS RELEASE 09.01.2023

Amgen and Horizon Therapeutics plc Resolve FTC Lawsuit, Clearing Path to Close Acquisition
$link.Title
PATIENTS 08.28.2023

Hidden Areas, Visible Impact: A Woman’s Struggle with Moderate to Severe Genital Psoriasis
$link.Title
PATIENTS 08.25.2023

4 Ways Amgen Works to Cut Heart Attacks and Strokes Through LDL-C Testing
$link.Title
PATIENTS 08.23.2023

Amgen Joins Forces with American Heart Association on Lower Your LDL Cholesterol Now™
$link.Title
PATIENTS 08.22.2023

Traveling with Severe Asthma: Tips for a Well-Managed Journey
$link.Title
RESPONSIBILITY 08.09.2023

A Passion for Science; A Love of Culture
KRAS G12C

Visit Our KRAS G12C Information Center
MORE STORIES

Our Latest Press Releases

PRESS RELEASE white-right-arrow

PRESS RELEASE white-right-arrow

PRESS RELEASE white-right-arrow

PRESS RELEASE white-right-arrow

PRESS RELEASE white-right-arrow

More News


Global hotline for Ukrainian refugee patients participating in an Amgen clinical trial.
Click here for more information.

Our Story

Watch VideoLearn more

Our Science

Amgen is a pioneer in the science of using living cells to make biologic medicines.

Our Products

Amgen’s medicines treat serious illnesses and typically address diseases with a limited number of treatment options.

Our Responsibility

Making a positive difference in the world is at the heart of what we do at Amgen—and it goes beyond making vital medicines.
Social Justice and Health Equity
View All
$name
12.03.2020
Amgen Foundation Announces Recipients of $5.25M to Support Social Justice and Equal Opportunity
$name
12.10.2020
Amgen Joins Coalition to Hire One Million Black Americans Over 10 Years
$name
05.31.2020
CEO Bob Bradway Shares Perspective on Death of George Floyd
$name
06.30.2020
Amgen Foundation Announces $7.5M to Support Racial Justice and Equal Opportunity
$name
10.05.2020
Coming Together to Advance Healthcare Equity
$name
11.17.2020
A Conversation on Social Justice: Amgen’s CEO and Echoing Green’s President

Amgen Investors

Amgen is a pioneer in the science of using living cells to making biologic medicines, leading and guiding the biotech industry.

Careers With Amgen

Encounter opportunities both new and undiscovered, as we embrace leading-edge technologies, invest in our talents, and maximize our potential.